ClinVar Miner

Submissions for variant NM_004415.4(DSP):c.3646A>G (p.Ile1216Val)

gnomAD frequency: 0.00011  dbSNP: rs199795359
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000171915 SCV000055167 uncertain significance not provided 2013-06-24 criteria provided, single submitter research
GeneDx RCV000038029 SCV000233606 uncertain significance not specified 2013-03-08 criteria provided, single submitter clinical testing p.Ile1216Val (ATT>GTT): c.3646 A>G in exon 23 of the DSP gene (NM_004415.2). The Ile1216Val variant in the DSP gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Although Ile1216Val results in a conservative amino acid substitution of one non-polar amino acid for another, this substitution occurs at a position that is conserved across species. The Ile1216Val variant was not observed in approximately 6000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, Ile1216Val was observed in 0.4% of Asian alleles in the 1000 Genomes database. In silico algorithms are not consistent in their predictions but at least two concur that Ile1216Val is benign to the protein structure/function. In addition, mutations in nearby residues have not been reported (van der Zwaag P et al., 2009) indicating this region of the protein may tolerate change. With the clinical and molecular information available at this time, we cannot definitively determine if Ile1216Val is a disease-causing mutation or a rare benign variant. The variant is found in ARVC panel(s).
Ambry Genetics RCV000247902 SCV000320258 likely benign Cardiovascular phenotype 2018-04-10 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV001087636 SCV000555777 likely benign Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8 2024-01-21 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001182251 SCV001347639 likely benign Cardiomyopathy 2018-11-05 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001182251 SCV002043291 benign Cardiomyopathy 2021-05-03 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000038029 SCV000061695 uncertain significance not specified 2008-03-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.